中国抗体-B(03681.HK) 公布2025年度业绩,录得亏损1.05亿人民币(下同),相较上年度亏损1.85亿元;每股亏损9分。不派末期息。年内并无确认收益。(de/d)(港股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2025/08/29中期业绩无派息2025/03/31末期业绩无派息2024/08/19中期业绩无派息2024/03/25末期业绩无派息AASTOCKS新闻
Source Link中国抗体-B(03681.HK) 公布2025年度业绩,录得亏损1.05亿人民币(下同),相较上年度亏损1.85亿元;每股亏损9分。不派末期息。年内并无确认收益。(de/d)(港股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2025/08/29中期业绩无派息2025/03/31末期业绩无派息2024/08/19中期业绩无派息2024/03/25末期业绩无派息AASTOCKS新闻
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.